Bionano Genomics
BNGO
50 hedge funds and large institutions have $1.75M invested in Bionano Genomics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 7 closing their positions.
460% more call options, than puts
Call options by funds: $56K | Put options by funds: $10K
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
6% more funds holding
Funds holding: 47 → 50 (+3)
0.01% less ownership
Funds ownership: 0.11% → 0.1% (-0.01%)
29% less capital invested
Capital invested by funds: $2.47M → $1.75M (-$720K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$145K |
| 2 |
Jane Street
New York
|
+$117K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$75K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.7K |
| 5 |
Renaissance Technologies
New York
|
+$45.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$241K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$89K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$70.9K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$64.7K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$46K |
BNGO Hedge Fund Activity: Q4 2024 in Review
50 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q4 2024, worth a combined $1.75M — down 29% from $2.47M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BNGO positions and 7 closed out — a net gain of 5 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $145K. The largest seller was GMT Capital, exiting entirely with an estimated $241K sold.
- 50 institutional investors held Bionano Genomics (BNGO) as of Q4 2024, up from 47 in Q3 2024.
- Funds reported $1.75M of Bionano Genomics stock for Q4 2024, down 29% quarter-over-quarter.
- 12 funds opened new Bionano Genomics positions in Q4 2024 and 7 closed out, a net change of +5 holders.
- The largest Bionano Genomics buyer in Q4 2024 was Morgan Stanley, an estimated $145K added.
- The largest Bionano Genomics seller in Q4 2024 was GMT Capital, an estimated $241K sold.
Based on aggregated 13F filings for Q4 2024.